贝达药业：MCLA-129临床试验有序推进，重大进展将及时披露
Betta Pharmaceuticals Co., Ltd.(SZ:300558) Xin Lang Cai Jing·2026-01-12 01:16Group 1 - The company is currently advancing the clinical trial work for MCLA-129 in an orderly manner [1] - The company will promptly announce any significant progress regarding MCLA-129 [1]